Nektar Therapeutics
(NKTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,358 | -6,647 | -6,130 | -102,519 | -94,843 |
| Depreciation Amortization | 12,499 | 8,334 | 4,149 | 14,881 | 11,076 |
| Accounts receivable | -752 | -4,645 | -2,908 | 6,034 | 4,505 |
| Accounts payable and accrued liabilities | 1,755 | 2,183 | 1,748 | -8,046 | -4,047 |
| Other Working Capital | -85,959 | -63,703 | -35,691 | 117,708 | -13,852 |
| Other Operating Activity | 11,537 | 10,362 | 4,669 | 11,681 | 6,708 |
| Operating Cash Flow | $-76,278 | $-54,116 | $-34,163 | $39,739 | $-90,453 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -22,160 | -8,796 | -3,973 | -20,702 | -10,763 |
| Net Acquisitions | N/A | N/A | N/A | -4,440 | N/A |
| Purchase Of Investment | -315,160 | -218,275 | -115,277 | -451,918 | -298,054 |
| Sale Of Investment | 371,196 | 249,453 | 120,271 | 328,025 | 278,125 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -4,440 |
| Investing Cash Flow | $33,876 | $22,382 | $1,021 | $-149,035 | $-35,132 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,119 | -731 | -359 | -1,285 | -935 |
| Common Stock Issued | 7,142 | 6,148 | 4,776 | 4,820 | 3,821 |
| Financing Cash Flow | $6,023 | $5,417 | $4,417 | $3,535 | $2,886 |
| Exchange Rate Effect | -312 | -36 | -300 | -226 | -108 |
| Beginning Cash Position | 49,597 | 49,597 | 49,597 | 155,584 | 155,584 |
| End Cash Position | 12,906 | 23,244 | 20,572 | 49,597 | 32,777 |
| Net Cash Flow | $-36,691 | $-26,353 | $-29,025 | $-105,987 | $-122,807 |
| Free Cash Flow | |||||
| Operating Cash Flow | -76,278 | -54,116 | -34,163 | 39,739 | -90,453 |
| Capital Expenditure | -22,160 | -8,796 | -3,973 | -20,702 | -10,763 |
| Free Cash Flow | -98,438 | -62,912 | -38,136 | 19,037 | -101,216 |